Evidence map›Paper›PMID 29642633›Full record

ArticleInternational journal of molecular sciences2018

Structural Requirements of Alkylglyceryl-l-Ascorbic Acid Derivatives for Melanogenesis Inhibitory Activity.

Norihisa Taira, Yushi Katsuyama, Masato Yoshioka, Osamu Muraoka, Toshio Morikawa

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.8field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 15 citations in OpenAlex.

  1. Disrupting melanin transfer: innovative strategy for anti-pigmentation drug discovery.Journal of enzyme inhibition and medicinal chemistry · 2025
    Review
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Skin Pigmentation: Is the Control of Melanogenesis a Target within Reach?International journal of molecular sciences · 2018
    Article
  8. The effect of Vitamin C on melanin pigmentation - A systematic review.Journal of oral and maxillofacial pathology : JOMFP
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Norihisa TairaSEIWA KASEI CO, LTD., 1-2-14, Nunoichicho, Higashi-osaka, Osaka 579-8004, Japan. Taira_Norihisa@seiwakasei.co.jp.
Yushi KatsuyamaSEIWA KASEI CO, LTD., 1-2-14, Nunoichicho, Higashi-osaka, Osaka 579-8004, Japan. katsuyama_yushi@seiwakasei.co.jp.
Masato YoshiokaSEIWA KASEI CO, LTD., 1-2-14, Nunoichicho, Higashi-osaka, Osaka 579-8004, Japan. yoshioka_masato@seiwakasei.co.jp.
Osamu MuraokaPharmaceutical Research and Technology Institute, Kindai University, 3-4-1 Kowakae, Higashi-osaka, Osaka 577-8502, Japan. muraoka@phar.kindai.ac.jp.
Toshio MorikawaPharmaceutical Research and Technology Institute, Kindai University, 3-4-1 Kowakae, Higashi-osaka, Osaka 577-8502, Japan. morikawa@kindai.ac.jp.ORCID 0000-0003-2794-5365
Kindai University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

l-Ascorbic acid has multifunctional benefits on skin aesthetics, including inhibition of melanin production, and is widely used in cosmetics. It, however, has low stability and poor skin penetration. We hypothesize that alkylglyceryl-l-ascorbic acid derivatives, highly stable vitamin C-alkylglycerol conjugates, would have similar anti-melanogenic activity with better stability and penetration. We test 28 alkylglyceryl-l-ascorbic acid derivatives (

Indexed as

AnimalsAscorbic AcidCell LineCell Line, TumorHumansMelaninsMelanocytesMiceQuantitative Structure-Activity RelationshipSkin Lightening PreparationsAscorbic AcidMelaninsSkin Lightening Preparations2-O-(2,3-dihydroxypropyl)-3-O-hexyl-3-O-(2,3-dihydroxypropyl)-2-O-hexyl-alkylglyceryl-">l-ascorbic acidmechanism of actionmelanogenesis inhibitorstructural requirement

Identifiers

PMID29642633
PMCPMC5979531
OpenAlexW2797302869

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.